XENON PHARMACEUTICALS INC. Conversion of Stock, Amount Issued
XENON PHARMACEUTICALS INC. (XENE) reported Conversion of Stock, Amount Issued of $124.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2017-03-08
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for the quarter ending 2014-12-31 was $92.00K, a 253.85% increase year-over-year.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for the quarter ending 2014-09-30 was $5.00K.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for the quarter ending 2014-06-30 was $13.00K.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for the quarter ending 2014-03-31 was $14.00K.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for fiscal 2014 was $124.00K, a 175.56% increase from fiscal 2013.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for fiscal 2013 was $45.00K, a 104.55% increase from fiscal 2012.
- XENON PHARMACEUTICALS INC. conversion of stock, amount issued for fiscal 2012 was $22.00K.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|
| 2014-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $97.00K derived: sum of 2 quarters · filed 2017-03-08 | $110.00K derived: sum of 3 quarters · filed 2017-03-08 | $124.00K 10-K · filed 2017-03-08 |
| 2014-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $18.00K derived: sum of 2 quarters · filed 2015-11-10 | $32.00K 10-Q · filed 2015-11-10 | $58.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | $13.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-13 | $27.00K 10-Q · filed 2015-08-13 | $53.00K derived: sum of 3 quarters · filed 2016-03-08 | |
| 2014-03-31 | $14.00K 10-Q/A · filed 2015-08-13 | $40.00K derived: sum of 2 quarters · filed 2016-03-08 | ||
| 2013-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $45.00K 10-K · filed 2016-03-08 | ||
| 2013-09-30 | $19.00K 10-Q · filed 2014-12-15 | |||
| 2012-12-31 | $22.00K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |